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Gaseous oxygen is essential for all aerobic animals, without which mitochondrial
respiration and oxidative phosphorylation cannot take place. It is not, however, regarded
as a “nutrient” by nutritionists and does not feature as such within the discipline of
nutritional science. This is primarily a consequence of the route by which O2 enters
the body, which is via the nose and lungs in terrestrial animals as opposed to the
mouth and gastrointestinal tract for what are customarily considered as nutrients. It
is argued that the route of entry should not be the critical factor in defining whether
a substance is, or is not, a nutrient. Indeed, O2 unambiguously meets the standard
dictionary definitions of a nutrient, such as “a substance that provides nourishment
for the maintenance of life and for growth” (Oxford English Dictionary). O2 is generally
available in abundance, but deficiency occurs at high altitude and during deep sea
dives, as well as in lung diseases. These impact on the provision at a whole-body level,
but a low pO2 is characteristic of specific tissues includings the retina and brain, while
deficiency, or overt hypoxia, is evident in certain conditions such as ischaemic disease
and in tumours - and in white adipose tissue in obesity. Hypoxia results in a switch
from oxidative metabolism to increased glucose utilisation through anaerobic glycolysis,
and there are extensive changes in the expression of multiple genes in O2-deficient
cells. These changes are driven by hypoxia-sensitive transcription factors, particularly
hypoxia-inducible factor-1 (HIF-1). O2 deficiency at a whole-body level can be treated
by therapy or supplementation, but O2 is also toxic through the generation of reactive
oxygen species. It is concluded that O2 is a critical, but overlooked, nutrient which
should be considered as part of the landscape of nutritional science.
Keywords: adipocyte, adipose tissue, hypoxia, hypoxia-inducible factor-1 (HIF-1), mitochondria, oxygen
deficiency, respiration
INTRODUCTION
There is a general understanding of what constitutes the field of nutritional science. At its
core, the discipline encompasses the provision of macro- and micro-nutrients, how they are
processed in order to meet the requirements of the individual (whether humans or other species)
for maintenance—and at certain points in the life cycle, for growth and development. From a
biomedical perspective, the focus is with the consequences of under– or over-provision with regard
to health and the prevention of disease. Most nutritional scientists understand macronutrients
to mean proteins, carbohydrates, and lipids, each of which include multiple molecular entities.
Alcohol may also be classified as a macronutrient, and in some cultures makes a significant
contribution to total energy intake.
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There are, however, two major nutrients which are essentially,
or entirely, ignored in nutrition, not least in textbooks of
the subject, and water is the most obvious example. Water
is, of course, contained within most foods and is released
during digestion; it is also obtained as a by-product of multiple
metabolic processes. There is nonetheless, a distinct requirement
for additional water, particularly in hot environments and
in situations such as during extreme exertion when the losses
are high. Indeed, the provision of (clean) water for direct
consumption is a critical determinant of the health and survival
of man and other animals. Water is consumed as such both
during and between meals, and enters the body in a manner
similar to that of other nutrients.
The other forgotten, though quantitatively major nutrient, is
diatomic oxygen. O2 has, however, rarely been considered as a
nutrient in the customary sense of the term, certainly in the
case of humans and other higher animals; this is despite earlier
arguments that it should be so considered, though the proponents
were equivocal (1). Indeed, its classification as a nutrient would
be regarded as controversial by many nutritionists. In the present
article, the proposition that O2 is unambiguously a nutrient
(1, 2) and should be included within the landscape of nutritional
science is developed.
DEFINITIONS—WHAT IS A NUTRIENT?
Whether O2, a gas, is a macro (in the sense of quantity) nutrient
and part of the remit of nutrition depends, of course, on the
meaning of the word “nutrient”. There is a commonplace sense
of what constitutes a nutrient—as something that is eaten within
food and which is necessary for bodily maintenance and good
health. However, dictionaries have, as would be expected, clear
definitions of the term. In the Oxford Dictionary of English,
2nd edition (2005)—the Oxford dictionaries being the “bible” of
the English language—a nutrient is defined as “a substance that
provides nourishment for the maintenance of life and for growth”.
Its American equivalent, Webster’s, is perhaps even more precise
in its definition, a nutrient being “any substance or matter that is
needed for the life and growth of living things”. Other dictionaries
offer similar definitions (e.g., Collins English Dictionary: “any
substance that nourishes an animal”), although the word “food”
is sometimes included by those that are medical in focus.
It is clear from these definitions that O2, as well as water,
is unambiguously a nutrient. In the case of water, its inclusion
would not be considered controversial, given that it is consumed
via the mouth and is absorbed from the gastrointestinal tract
similar to those substances that are classically regarded as
nutrients. The provision of O2 is, of course, fundamentally
different in that it is obtained from the ambient air as a gas and
delivered through the nose and lungs (or gills in the case of
aquatic animals). It is this route of entry into the body which
is the primary reason why O2 is not regarded as a nutrient in
humans and other higher animals, and is absent from nutritional
discourse. Indeed, reference to O2 in a nutritional context is
invariably limited to metabolic rate and energy expenditure with
respect to energy balance and RQ (respiratory quotient).
It is argued that the actual route of entry—gastrointestinal
tract or lungs/gills—should not be considered a defining
characteristic of a substance as a nutrient, but rather the
functions and essentiality as delineated in the dictionary
definitions above (Table 1). With considerable insight, the Polish
alchemist Michael Sendivogius wrote as far back as 1604 that
“Man was created of the Earth, and lives by virtue of the air;
for there is in the air a secret food of life.....” (my italics) (3).
This was, of course, well-before the formal discovery of O2,
though Sendivogius in effect hypothesised its existence. The
discovery of O2 as such in the latter half of the 18th century
is variously credited to the English chemist Joseph Priestley,
the Swedish apothecary Carl Scheele, and the French chemist
Antoine Lavoisier, each contributing in different respects.
The word oxygen is derived from the Greek for “acid-former”
(oxys—sharp, sour and genes—producer), which referred to the
mistaken view that it was necessary for the formation of acids.
The name was first coined by Lavoisier (French, oxygène) who
showed that combustion was the reaction of O2 with carbon and
other substances.
OXYGEN AND THE ORIGINS OF LIFE
It is an axiom that life on Earth as we know it is dependent
on the presence of an atmosphere containing O2. Gaseous
oxygen has been detected elsewhere in the universe, its presence
in the atmosphere of distant exoplanets providing a potential
biomarker for life (4–6). When the Earth first formed 4.54
billion years ago through accretion from the solar nebula, the
primordial atmosphere was devoid of O2—there was no free
O2 (7, 8). The diatomic oxygen that was present was essentially
locked up in rocks and in water, and some 4 billion years ago the
atmosphere was thought to have contained O2 at just one part in
a million (8, 9). The earliest single celled organisms existed under
anoxic conditions and were superseded by cyanobacteria, which
appeared up to 3 billion years or more ago—and, importantly,
generated O2 through photosynthesis (9). Microorganisms, such
as those harboured in deep sea hydrothermal vents, are able
to survive, indeed flourish, under anoxic conditions through
sulphur respiration—anaerobic respiration with sulphur (10, 11).
Approximately 2.45 billion years agoO2 began to appear in the
atmosphere in significant quantities at what is termed the “Great
Oxidation Event” (actually a protracted process) (9, 12, 13). O2
levels gradually increased, and probably then fell, until around
700 million years ago when a further sharp increase occurred
(12). The level of O2 in the atmosphere is believed to have
hovered at around the current 21% since ∼600 million years ago
(9).While O2 can be toxic inmany respects, as discussed in a later
section, its rise was critical to the development of multi-cellular
organisms and the physiological complexity that this implies.
The earliest known fossils of a eukaryote, from which multi-
cellular organisms evolved, date from at least 2 billion years ago
(14). In eukaryotes and early multi-cellular organisms requiring
O2, uptake occurs by direct transfer across the cell membrane
in essentially the same manner as other nutrients prior to the
development of specialised digestive and respiratory organs.
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TABLE 1 | Characteristics of oxygen as compared to what are normally regarded as nutrients.
Oxygen Classical nutrients
Obtained from The ambient air (surrounding water in fish) Foods in the diet
Route of entry Nose and lungs (gills in fish) Mouth and gastrointestinal tract
Frequency of provision Essentially constant Generally periodic
Processing No prior processing Requires processing by digestion
Transportation Transported directly by a specific transporter (haemoglobin) In some cases transported by specific transporters
Storage Storage is minimal–essentially only in muscle (myoglobin) in some
species for local use
May be stored for future use (e.g., fatty acids as triacyglycerols in
adipose tissue, and glucose as glycogen in liver)
Deficiency Available in abundance–but deficiency at high altitudes, during deep
diving, in specific ecological niches and in lung diseases.
Major cellular and molecular adaptations to reduced levels
Well-recognised deficiency diseases for most nutrients
Toxicity Some toxicity at normal levels Excess can be toxic for specific nutrients (e.g., vitamin A, selenium)
RDA Potentially-to maintain energy balance and to meet requirements for
growth, pregnancy and lactation
Yes
The ready availability of O2 had a profound effect on the
metabolic opportunities for an organism and the consequent
systems that developed. The mitochondrion, through respiration
and oxidative phosphorylation, is a potent example of a
cellular organelle whose evolution resulted in major new
metabolic processes. The most widely accepted view on the
origin of mitochondria is the endosymbiotic hypothesis which
proposes that mitochondria were originally prokaryotic cells
(14, 15). These prokaryotes were able to undertake oxidative
processes that early eukaryotic cells could not perform, and they
subsequently became endosymbionts living within the eukaryote
cell structure.
PROVISION AND DELIVERY OF O2
Animals are constant metabolisers, whether they are
poikilotherms or homeotherms, and this is so even in those
species that undergo periods of hibernation, aestivation or torpor
(albeit at a reduced rate of metabolism). However, most nutrients
are obtained in higher animals on an intermittent basis, such
species being periodic feeders—whether in the form of distinct
meals or through frequent foraging. Foods, entering through the
mouth, are generally complex structures and the nutrients that
they contain are not immediately available. Instead, they require
release through digestion and are subsequently absorbed from
the gastrointestinal tract, a process that may involve specific
transporters.
In simple organisms, O2 is obtained in a manner similar
to that of other nutrients—by absorption across the cell
membrane—while in complex organisms it is fundamentally
different. The evolution of specialised organs has resulted
in the development of a respiratory system for the delivery
of O2, differentiating it sharply from the route by which all
other nutrients are provided through the digestive system
(Table 1). In marked contrast to nutrients obtained via the
mouth and gastrointestinal tract, the requirement for O2 is
virtually continuous in higher animals; as is well-recognised,
the absence of O2 results in death within a very few minutes in
humans and many other higher species. This reflects both the
constant metabolic need for O2 together with the absence of
any significant storage. There is some limited storage, however,
in skeletal muscle for local use through binding to the iron-
containing protein myoglobin, but this is primarily a feature
of marine animals such as whales, which experience apnoea
during diving and where the haem protein is present in relative
abundance (16).
On entering the lungs, O2 passes into the alveoli which as
highly vascularised sacs enable the rapid movement of the gas
by simple diffusion, first across the alveolar epithelium and
then the endothelial cells of the alveolar capillaries. Once in the
circulation, O2 binds to haemoglobin in the erythrocytes and
is immediately transported to tissues (17). Modifications to this
route of entry occur through the presence of gills in aquatic
species, while in lower animals simpler systems for obtaining O2
are evident.
The presence of haemoglobin as a specific carrier for O2 has
some parallels with the transport and delivery of a number of
other nutrients. There are selective carriers for the movement
of nutrients from the lumina of the gastrointestinal tract—
such as the Na+-dependent glucose transporter (SGLT1) to
transfer glucose (18, 19), and several amino acid transporters
to transfer various amino acids (19, 20). Once across the
gastrointestinal wall, from mucosal to serosal side, nutrients
move to their immediate sites of action or to storage organs
for subsequent use. Storage occurs particularly in the liver
and skeletal muscle for glucose as glycogen, and in white
adipose tissue depots for the sequestration of fatty acids as
triacylglycerols (19). In some cases, carrier proteins are involved
in the transport of nutrients to their storage site, such as
transferrin for the transport of iron to the bone marrow (21).
Specific carriers, analogous to haemoglobin, also transport a
number of nutrients to the tissues where they are required
once released from storage, examples including retinol binding
protein for retinol (21, 22) and plasma lipoproteins in the case of
lipids (19, 23).
METABOLIC FUNCTION OF O2
Despite O2 not being recognised as a nutrient in the context of
nutritional science and in relation to whole-body physiology, it
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is frequently described as such in studies at a cellular level [e.g.,
(1, 24)]. The central role of O2 as a nutrient is in mitochondrial
respiration, acting as an electron acceptor thereby enabling ATP
to be formed through oxidative phosphorylation. This process is
fundamental to aerobic organisms, with the oxidation of glucose
and fatty acids requiring the continuous provision of O2. Several
core metabolic pathways are central to mitochondrial oxidative
phosphorylation—glycolysis, glycogenolysis, lipolysis, and the
tricarboxylic acid (Krebs) cycle (19).
There are differences between cell types in the number
of mitochondria that are present, as well as in the relative
development of their cristae structure, according to the level of
respiration and oxidative phosphorylation that is functionally
required.White adipocytes, for example, havemoderate numbers
of mitochondria which contain limited cristae, with most of
the volume of these cells being due to the lipid droplet (25, 26).
Brown adipocytes, in marked contrast, contain large numbers
of mitochondria with a highly developed and dense cristae
structure, especially in rodents adapted to cold environments
when maximum non-shivering thermogenesis is required
(25, 26). In these circumstances, brown fat mitochondria utilise
substantial amounts of O2 in order to sustain the oxidation of
fatty acids and other substrates at high rates, with ATP synthesis
being bypassed through a proton leakage pathway regulated by
UCP1 (uncoupling protein-1) (27).
DEFICIENCY OF OXYGEN
The partial pressure of O2 is highest at sea level, but falls
with altitude leading to a decrease in the amount available.
Altitude is one of the several environmental situations that
result in a reduction in the availability of O2. Animals, including
humans, that habitually live at high elevations have evolved
distinct physiological adaptations which allow them to adapt
to the relatively hypoxic conditions. Another environmental
circumstance in which O2 deprivation occurs, albeit on a
short-term basis, is that experienced by aquatic mammals such
as whales during deep sea dives.
Even at sea level, a marked periodic lack of O2 is also evident
in certain terrestrial species according to their precise ecological
niche. Naked mole-rats (Heterocephalus glaber) are a potent
example, these animals experiencing near anoxic conditions
during prolonged periods in their subterranean burrows (28).
The ability of naked mole-rats to withstand sustained anoxia
is suggested as being due to the utilisation of fructose as a
fuel for glycolysis, through high levels of the GLUT5 fructose
transporter and of ketohexokinase, enabling the key glycolytic
regulatory enzyme phosphofructokinase to be bypassed (28).
Some ectothermic vertebrates, such as the American freshwater
turtle and crucian carps, exhibit extreme capacities to withstand
a low O2 tension, being able to survive for months under what is
effectively complete anoxia (29).
These examples of O2 deprivation relate to specific
environmental and ecological conditions to which particular
species are exposed and effect provision of the macronutrient in
whole-animal terms. A fall in the availability of O2 to the body
TABLE 2 | Oxygen level (pO2) in ambient air and in selected tissues.
Tissue pO2 in mmHg (References)
Ambient (inspired) air at sea level 160 (7)
Alveolar blood 104 (7)






White adipose tissue-lean mice 47.9 (37)
White adipose tissue-obese mice 15.2 (37)
as a whole can also occur in certain disease states, primarily
disorders of the lungs (30). There are several major human lung
diseases, some of which are often given the collective name of
chronic obstructive pulmonary disease, that lead to impairments
in O2 delivery; these include emphysema, pulmonary fibrosis
and cystic fibrosis (31). Such conditions result in a chronic
insufficiency of O2, but there are also situations in which there is
an acute, periodic lack as in obstructive sleep apnoea (32).
The O2 tension of inspired air at sea level is 160 mmHg (21.3
kPa) while in alveolar blood it is around 104 mmHg (13.9 kPa),
the level at which it leaves the lungs (7). The general level of
tissue oxygenation is rather lower at some 40–50 mmHg (5.33–
6.67 kPa); thus, even the “normal” tissue pO2 is in effect hypoxic
relative to alveolar blood and ambient air at sea level (7, 33).
However, a substantially lower O2 tension is evident in several
tissues, including the spleen, thymus, retina and regions of the
brain (which is a substantial consumer of O2) with a pO2 of 16
(2.13 kPa), 10 (1.33 kPa), 2–25 (0.27–3.33 kPa) and 0.4–8 mmHg
(0.05–1.07 kPa), respectively (see Table 2) (34–36). Tumours are
also markedly hypoxic, with pO2 values ranging from 1 to 10
mmHg (0.13–1.13 kPa) - and the centre of solid tumours may
be essentially anoxic (7, 33, 34). These examples of low pO2 in
certain tissues generally reflect limited vascularisation, as in the
retina and in tumours, and the consequent distance that O2 has
to travel to the cells where it is required. The diffusion distance
of O2 is generally considered to be of the order of 100–200µm –
the size of large white adipocytes (38) - but there are reports of a
pO2 close to zero at only 100µm from the capillaries (7, 39).
There are other pathological conditions, in addition to
tumours, in which overt tissue hypoxia is evident. These include
psoriasis and ischaemic disorders, and at the site of wounds
during healing (7, 40, 41). A further example is with white
adipose tissue depots in obesity, at least in rodents (41). The
pO2 of white fat in lean mice is around 45–50 mmHg (6.00–6.67
kPa), similar to the general level of tissue oxygenation, but in
obese mice it is between 2- and 3.5-fold lower at ∼15 mmHg
(2.00 kPa), as assessed with needle-type fibre optic O2 sensors
(37, 42–44). This reduction is evident in genetically obese (ob/ob)
mice and in mice made obese through the provision of a high fat
diet (37, 42, 43, 45). The functional implications of this marked
reduction in pO2 in white fat depots in obesity is considered in a
later section.
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CELLULAR AND MOLECULAR
ADAPTATIONS TO OXYGEN DEFICIENCY
Cells have highly developed systems for detecting O2 levels and
for adapting to deficiencies. O2 is sensed at the cell membrane
by specific ion channels, particularly K+ channels (46–48).
Within the cell, there are a series of transcription factors
which are responsive to O2 and which drive the molecular
adaptations to hypoxia. These include NFκB and CREB
(cAMP response element-binding protein) (49), but the central
transcription factors sensitive to hypoxia are the HIFs (hypoxia-
inducible factors). There are three HIFs, of which HIF-1 is
considered the most significant—and certainly the most widely
studied (50–52).
HIF-1 is a heterodimer, the subunits being HIF-1α and
HIF-1β. HIF-1β is constitutively expressed, and although
HIF-1α is constantly synthesised it is rapidly degraded under
normal cellular levels of O2 (7, 52–54). The mechanism
by which HIF-1α is degraded has been extensively studied;
in essence, degradation is through the 26S proteosomal
system and involves the hydroxylation of HIF-1α. The
HIF-1α subunit is stabilised when the O2 level is low,
enabling the functional dimeric HIF-1 transcription factor
to be produced.
The other HIFs - HIF-2 and HIF-3 - are formed by the
dimerisation of HIF-1β with HIF-2α and HIF-3α, respectively
(52, 55). These HIFs appear to be more limited in their action
than HIF-1, particularly HIF-3, and are more tissue specific.
HIF-1 regulates the transcription of in excess of 100 genes,
these encoding proteins involved in several distinct cellular and
metabolic systems (24, 40, 53). Importantly, enzymes and other
proteins associated with glucose utilisation and glycolysis are
regulated by HIF-1. Amongst the genes related to glycolysis that
are up-regulated in response to hypoxia, though not necessarily
by a HIF-1 dependent mechanism, areGPI (glucose-6-phosphate
isomerase), HK2 (hexokinase 2) and PFKP (phosphofructokinse
platelet). There is also up-regulation by hypoxia of the expression
of the gene encoding GLUT1, the facilitative glucose transporter
responsible for basal glucose uptake, and this is widely used as a
molecular marker of the cellular response to low pO2(40, 41).
Increases in the expression of genes associated with glucose
uptake and utilisation reflect the augmentation of anaerobic
glycolysis that occurs under conditions of low pO2. One of the
consequences of greater glycolysis in hypoxia is a rise in the
production of lactate, associated with increased expression of
lactate transporters, MCT1 in particular in the case of adipocytes
for example (56). There are also parallel changes in the
expression of genes encoding mitochondrial enzymes and other
proteins involved in respiration and oxidative phosphorylation,
consequent to the reduction of these processes (57, 58).
Again using white adipocytes as an example, the expression
of genes such as ATP5D (ATP synthase, H+ transporting,
mitochondrial F1 complex, delta subunit) and COX4I1
(cytochrome c oxidase subunit 4, isoform 1) are down-regulated
in hypoxia (41, 58).
OXYGEN DEFICIENCY: THE EXAMPLE OF
WHITE ADIPOSE TISSUE
In addition to changes in glucose utilisation, oxidative
phosphorylation, and lipid oxidation, exposure to a low
pO2 leads to alterations in the expression of multiple genes
involved in several other pathways in white adipocytes, including
cell death and cell-to-cell signalling and interaction (58, 59);
indeed, the expression of ∼1,300 genes is altered in adipocytes
by hypoxia (58). These reflect general responses to hypoxic
conditions, many of which are near universal, especially those
linked to anaerobic glycolysis and oxidative phosphorylation.
However, some of cellular and molecular adaptations to a low
pO2 are specific to individual tissues, reflecting their particular
physiological function.
A clear example comes from white adipose tissue (Figure 1),
a tissue that has been a continuing focus in nutritional science.
This was originally in relation to the storage of triacylglycerols
as fuel, but subsequently as a consequence of the surge in the
incidence of obesity. More recently, white adipose tissue has
been recognised as a major endocrine and signalling organ,
being implicated in a range of physiological functions—from the
regulation of appetite and blood pressure to insulin sensitivity
and the inflammatory response (41, 60). Much of this recent
regulatory perspective on white fat centres on the multiplicity
of protein factors—the adipokines—that are released by white
adipocytes, and which number several hundreds (61). This has
followed from the discovery of the hormone leptin, adipocytes
being the major site of production of this pleiotropic endocrine
factor (62).
Expression of the leptin (LEP) gene and secretion of the
mature protein hormone are markedly stimulated by hypoxia
(63), and indeed a low O2 tension induces preadipocytes to
produce the hormone (64)—which they do not when incubated
under so-called “normoxic” conditions (21%O2). Thus, exposure
to O2 deficiency leads to a substantial increase in the production
of a key adipocyte hormone. Another major adipocyte hormone,
adiponectin, responds to hypoxia in the opposite direction, there
being a reduction in the expression of the ADIPOQ gene and
in the secretion of the encoded protein (63). This particular
change would be expected to lead to a fall in insulin sensitivity
and increased inflammation, given the insulin sensitising and
anti-inflammatory actions of adiponectin (65–68).
Inflammation is one of the characteristics of adipose tissue
as it enlarges in obesity, with recruitment of M1 macrophages
and increased expression and release of a number of cytokines
and chemokines, as well as of other inflammation-related factors
(60, 69–71). Exposure of white adipocytes to hypoxic conditions,
at least in cell culture, leads for example to increases in the
expression of the IL6, VEGF, PAI1, MIF, MMP2, and MMP9
genes, in addition to the LEP gene, as part of the inflammatory
response (45, 63, 72). Inflammation in adipose tissue, driven by
hypoxia (41, 51), is considered to underpin the development
of the major obesity-associated diseases, particularly insulin
resistance, type 2 diabetes and the metabolic syndrome (73, 74).
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FIGURE 1 | Schematic representation of some of the central cellular responses to hypoxia (oxygen deficiency) in white adipocytes. The figure illustrates adaptations
that are universal to all cell types, particularly the increase in glucose utilisation through anaerobic glycolysis and the reduction in respiration and oxidative
phosphorylation (ox phos). Adaptations that are specific to adipocytes are also shown, primarily those relating to lipid utilisation and the production of adipokines as
key secretory proteins of these cell types; in some of the examples, such as MT-3 (metallothionein-3), only major changes at the gene expression level have been
formally documented. angptl4, angiopoietin-like protein-4; enzy, enzyme; FA, fatty acid; GLUT1, facilitative glucose transporter 1; HIF-1, hypoxia-inducible factor-1;
MCT1, monocarboxylate transporter-1; MIF, macrophage migration inhibitory factor; MMPs, matrix metalloproteinases; PAI-1, plasminogen activator inhibitor-1; TF,
transcription factors (additional to HIF-1); VEGF, vascular endothelial growth factor. Adapted from (1).
Most in vitro and cell culture studies on adipocytes, and
indeed of other types of cell, use a protocol in which the response
to 1 or 2% O2 is compared to that of a reference level of 21%
O2. As noted previously, this represents an extreme with 21%
O2 being in effect hyperoxia while 1% O2 is at the bottom
end of normal tissue oxygenation. Despite being an extreme, it
can be justified by enabling “proof of principle” to be explored,
even though it may exaggerate the scale of the response to O2
deprivation. Studies in which human adipocytes are incubated
with graded levels of O2 between 21 and 1% indicate that indeed
the response is exaggerated (75). They also demonstrate that
there is not a critical threshold at which adaptive changes to low
pO2 occur, but rather that there is a graded “dose response” (75).
This is true for a range of processes, including glucose uptake
and lactate release, and to the expression and secretion of leptin,
VEGF and other adipokines (75). Thus, adipocytes titre small
changes in O2 tension (provision) across a range of metabolic
systems and processes, and this is also likely to occur in other
cell types.
OXYGEN THERAPY AND TOXICITY
When there is a deficiency of O2, amelioration is possible through
increasing its provision by O2 therapy, or supplementation. O2
therapy has its origins in the Pneumatic Institution founded in
Bristol (UK) in 1799 by Thomas Beddoes, the aim of which
was to explore the potential efficacy of the gas for the treatment
of disease (76). Treatment now may be acute, as in medical
emergencies such as for resuscitation, trauma and anaphylaxis,
or chronic as in lung diseases, including chronic obstructive
pulmonary disease and emphysema (30). Supplemental O2 is also
utilised by mountaineers at high altitudes and in aircraft in the
event of a fall in cabin pressure. These are, of course, relatively
extreme conditions, and this is also the case with hyperbaric O2
therapy to treat decompression sickness in deep-sea divers.
There is a Janus-faced dimension to O2 in that in addition to
being essential, it is toxic under certain conditions. For example,
giving O2 to newborn premature babies can lead to blindness
(77, 78), and O2 toxicity is a well-recognised risk of deep diving.
At a molecular level, O2 is toxic through the formation of
reactive oxygen species (ROS), these including peroxides, singlet
oxygen, hydroxy radical and superoxide (79, 80). Although ROS
are produced during normal metabolic functions involving O2,
and have important signalling roles, their accumulation leads
to cell damage and oxidative stress (79). Antioxidant defence
mechanisms detoxify ROS, and these encompass enzymatic
systems, in particular the superoxide dismutases, catalase and
glutathione peroxidases(79, 80).
RECOMMENDED ‘DIETARY’ ALLOWANCE
The concept of the recommended dietary allowance (RDA) is
based on the need to set standards for the intake of nutrients,
and this has been a continuing concern for national agencies and
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for Governments. The terminology associated with the general
concept has, however, become somewhat complex with different
countries adopting differing terms—“dietary reference value” in
the UK, “population reference intake” elsewhere in the European
Union, and “dietary reference intake” in the USA and Canada,
with many other countries still using RDA (81). Whichever term
is employed, standards are available for almost all nutrients,
including water.
The concept of a RDA (or equivalent) would appear
problematic for O2 – not least because of the word “diet” in
the term—and it is appropriate to ask whether in this case it is
relevant. Under most circumstances O2 is freely available and
essentially unlimited (with the exceptions described above), and
is obtained without financial cost. Intake is tightly controlled by
the respiratory system and is closely calibrated to requirements.
It can be argued that in adults the “RDA” for O2 is determined
essentially by the need to maintain energy balance so that
intake and expenditure are equal, especially in those of normal
body weight. This will depend, of course, on the overall dietary
composition in terms of other macronutrients and whether
lipids, proteins, or carbohydrates are being oxidised. It will also
depend on the level of physical activity as well as the stage in the
life cycle, the requirement being higher as with other nutrients
during growth, pregnancy and lactation.
CONCLUSIONS
Gaseous oxygen is not framed as a nutrient in nutritional
science (1), despite being essential for all aerobic organisms.
This primarily reflects the route of entry—the nose and lungs
(or gills), rather than the mouth and gastrointestinal tract which
is the path by which all other nutrients enter the body in higher
animals. In very simple organisms, there is no fundamental
difference in the mechanism by which O2 and other nutrients
are taken up, differentiation occurring only following the
evolution of specialised systems for digestion and respiration.
At the cellular level in higher animals, there is also no essential
distinction between O2 and what are conventionally considered
as nutrients.
Deficiency of O2 on a whole-body basis is apparent
in a number of situations, relating either to the specific
environmental niche or to particular disease states. Individual
tissues may experience a reduced pO2–relative hypoxia—
either as part of the physiological milieu to which they are
customarily exposed, or as a response to specific diseases. In
practise, most tissues are relatively hypoxic, and certainly in
relation to the O2 tension in alveolar blood. There are pervasive
adaptations at a cellular level to reduced pO2, with a major
switch in energy metabolism from mitochondrial respiration
and oxidative phosphorylation to anaerobic glycolysis. This
involves substantial shifts in the pattern of gene expression,
much of which is driven by specific transcription factors,
particularly HIF-1.
The concept of the RDA can be applied to O2, as with other
nutrients, and toxicity is evident in certain circumstances. It
is concluded that O2 is an important nutrient, and indeed
an essential one, that is required in large quantities and
which should be considered in conjunction with what are
conventionally regarded as nutrients. As such, O2 should be
firmly viewed as being part of the landscape of nutritional
science.
CODA
In the 4 August 2017 issue of Science, a series of Japanese haikus
on each element (“Elemental Haiku”) was presented by Mary
Soon Lee (82). The haiku for oxygen encapsulates the critical
biological importance of this element:
“Most of me is you.
I strive for independence,
Fail with every breath.”
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